Skip to main content
. 2020 Dec 4;2020(1):518–522. doi: 10.1182/hematology.2020000136

Figure 1.

Figure 1.

Days with bleeding of grade 2 or higher in all 3 treatment groups, according to morning platelet-count categories. Days with bleeding of grade 2 or higher in all 3 treatment groups, according to morning platelet-count categories. The percentage of days on which patients had bleeding of grade 2 or higher is shown, along with the associated 95% confidence intervals (dashed lines), according to the morning platelet-count category. Data are based on the 24 309 days during the study period on which patients had both a morning platelet count and information on bleeding of grade 2 or higher. Reprinted from Slichter et al1 with permission.